| dbo:abstract
|
- بي أف-219,061 (بالإنجليزية: PF-219,061) هي مادة تطورها فايزر ذات تأثير قوي وانتقائي تجاه . تجرى عليها الأبحاث لاحتمال فعاليتها في علاج . (ar)
- PF-219,061 is a drug that was under development by Pfizer which acts as a potent and highly selective agonist for the dopamine D3 receptor. It was under development as a potential medication for the treatment of female sexual dysfunction. It did not advance into clinical trials. (en)
|
| dbo:casNumber
| |
| dbo:fdaUniiCode
| |
| dbo:pubchem
| |
| dbo:thumbnail
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 4270 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:c
| |
| dbp:casNumber
| |
| dbp:chemspiderid
| |
| dbp:h
| |
| dbp:iupacName
| |
| dbp:legalStatus
| |
| dbp:n
| |
| dbp:o
| |
| dbp:pubchem
| |
| dbp:routesOfAdministration
| |
| dbp:smiles
|
- CCCN1CCO[C@@H]C2=CCO (en)
|
| dbp:stdinchi
| |
| dbp:stdinchikey
|
- WYEGTIGJSHGEID-ZDUSSCGKSA-N (en)
|
| dbp:unii
| |
| dbp:verifiedfields
| |
| dbp:verifiedrevid
| |
| dbp:width
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- بي أف-219,061 (بالإنجليزية: PF-219,061) هي مادة تطورها فايزر ذات تأثير قوي وانتقائي تجاه . تجرى عليها الأبحاث لاحتمال فعاليتها في علاج . (ar)
- PF-219,061 is a drug that was under development by Pfizer which acts as a potent and highly selective agonist for the dopamine D3 receptor. It was under development as a potential medication for the treatment of female sexual dysfunction. It did not advance into clinical trials. (en)
|
| rdfs:label
|
- بي أف-219061 (ar)
- PF-219,061 (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
